The incidence and risk factors of urinary tract infections in patients undergoing bladder tumor resection: a systematic review and meta-analysis
Abstract
To summarise the available evidence concerning the incidence and risk factors of UTIs in bladder cancer patients after surgery. Systematic searches were conducted on PubMed, Embase, Web of Science, Cochrane Library, CINAHL, the China National Knowledge Base Database (CNKI), Wanfang Database, Vips Database (VIP), and the China Biomedical Database (Sinomed). These searches encompassed literature from the inception of each database up to March 2025. This study adhered rigorously to the PRISMA guidelines. The quality of the studies included in the review was assessed using the Joanna Briggs Institute (JBI) Centre for Evidence-Based Health Care in Australia and the Newcastle-Ottawa Scale. A total of 19 original studies were included in this analysis, encompassing 5,905 patients. The meta-analysis results indicated that the incidence of UTIs in patients with bladder tumor resection was 22.3% [95% CI (17.7, 27.3)]. The identified risk factors for UTIs in patients with bladder cancer after surgery include diabetes, age, preoperative catheter indwelling, Use of antibiotics before surgery, and Operation time≥90 min. UTIs are higher in patients who have undergone bladder tumor resection. Clinical staff should prioritize preoperative assessment and risk stratification for UTIs. They must adhere to established guidelines and recommendations regarding the prophylactic use of antibiotics before surgery, maintain strict control of patients’ blood sugar levels, and manage catheters…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 5,905 participants or records.
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.